@krispi thanks for posting the article.
For AD treatment, the intention is that Xanamem be part of a drug cocktail, not administered on its own.
For cognitive decline in other indications, I don't know if it would be administered on its own.
- Forums
- ASX - By Stock
- ACW
- 11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis
11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis, page-5
-
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
CXO
Core Lithium narrowly beats guidance on FY24 spodumene production but 1Y returns still shattered
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
Add ACW (ASX) to my watchlist
|
|||||
Last
7.4¢ |
Change
0.004(5.71%) |
Mkt cap ! $199.2M |
Open | High | Low | Value | Volume |
7.1¢ | 7.4¢ | 7.1¢ | $182.2K | 2.510M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 437259 | 7.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.4¢ | 289428 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 416496 | 0.072 |
3 | 150392 | 0.071 |
4 | 315810 | 0.070 |
6 | 255478 | 0.069 |
8 | 753678 | 0.068 |
Price($) | Vol. | No. |
---|---|---|
0.074 | 289428 | 3 |
0.075 | 767777 | 10 |
0.076 | 1960268 | 7 |
0.077 | 1118181 | 3 |
0.078 | 600000 | 4 |
Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |